GCM
BNTX icon

Gallacher Capital Management’s BioNTech BNTX Stock Holding History

Gallacher Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
+2,448
New +$230K 0.13% 239
2025
Q3 		– Sell
-2,250
Closed -$240K – 304
2025
Q2 		$240K Buy
+2,250
New +$227K 0.11% 254
2025
Q1 		– Sell
-2,021
Closed -$230K – 288
2024
Q4 		$230K Sell
2,021
-159
-7% -$18.1K 0.11% 249
2024
Q3 		$259K Sell
2,180
-1,477
-40% -$136K 0.12% 222
2024
Q2 		$294K Buy
3,657
+395
+12% +$36.1K 0.15% 187
2024
Q1 		$301K Buy
3,262
+642
+25% +$61.6K 0.15% 188
2023
Q4 		$277K Buy
2,620
+630
+32% +$63.5K 0.15% 179
2023
Q3 		$216K Buy
+1,990
New +$220K 0.14% 208

Other funds holding BNTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CCP
Crocodile Capital Partners Ursensollen, Germany $147M AUM 67.67% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
S
Systrade Vaduz, Liechtenstein $160M AUM 73.26% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
MC
Mirabaud & Cie Geneva, Switzerland $249M AUM 43.75% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $1.6B AUM 23.66% 1-Year Est. Return

Gallacher Capital Management's BNTX Position: Q2 2026 in Review

Gallacher Capital Management opened a new position in BioNTech (BNTX) in Q2 2026: 2,448 shares worth $228K. The stake represents 0.13% of the portfolio and ranks #239 among its holdings. This is a return to the name: Gallacher Capital Management previously reported a position in BNTX as recently as Q2 2025.

Gallacher Capital Management first reported a position in BNTX in Q3 2023 and has held it in 8 quarters since. The position peaked at $301K in Q1 2024. 18 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Gallacher Capital Management held 2,448 shares of BioNTech worth $228K as of Q2 2026.
  • BioNTech was a new Gallacher Capital Management position in Q2 2026.
  • BioNTech made up 0.13% of Gallacher Capital Management's portfolio in Q2 2026, its #239 holding.
  • Gallacher Capital Management first reported a position in BioNTech in Q3 2023 and has held it in 8 quarters since.
  • Gallacher Capital Management's BioNTech position peaked at $301K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.